Mar 2, 2023 11:32AM
Mar 2, 2023 11:32AM
Feb 28, 2023 08:00AM
Feb 21, 2023 09:00AM
Feb 16, 2023 04:42PM
Feb 16, 2023 08:00AM
Feb 15, 2023 08:00AM BML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics
Feb 14, 2023 08:04AM
Feb 14, 2023 08:00AM
Feb 2, 2023 04:30PM
Jan 30, 2023 08:00AM
Jan 30, 2023 08:00AM
Jan 26, 2023 08:00AM
Jan 25, 2023 08:00AM Investor Group Issues Letter to the Boards of Sesen Bio and Carisma Rejecting Their Apparent Attempt to Purchase Merger Support
Jan 19, 2023 04:28PM
Jan 5, 2023 08:00AM
Jan 4, 2023 08:01AM
Jan 4, 2023 08:00AM
Jan 3, 2023 08:00AM
Dec 29, 2022 04:33PM
Dec 29, 2022 04:33PM Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend in Connection with Pending Merger
Nov 7, 2022 08:00AM
Sep 21, 2022 08:00AM
Sep 21, 2022 08:00AM
May 9, 2022 08:00AM
May 3, 2022 08:01AM
May 3, 2022 08:00AM
Nov 19, 2021 08:30AM 22nd Century Group (XXII) Announces CFO Transition
Nov 19, 2021 08:30AM
Feb 16, 2021 09:28AM
Jul 31, 2020 09:23AM
Feb 24, 2020 04:47PM
Feb 24, 2020 04:30PM
Aug 9, 2018 09:28AM
Aug 7, 2018 04:01PM Sesen Bio Announces CEO and Board Transitions as Company Prepares for 12-Month VISTA Trial Data and Regulatory Submission in 2019
Jul 23, 2018 09:31AM
Jul 9, 2018 09:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All